Skip to main content
Home » Advocacy » Patient Access & Health Equity » Pneumonia can be life-threatening, but ways exist to help protect yourself
Patient Access & Health Equity

Pneumonia can be life-threatening, but ways exist to help protect yourself


Pneumococcal vaccination can be an effective way to help protect seniors and other adults with increased risk from pneumonia.

Pneumonia is an infection of the lungs that can cause mild to severe illness in people of all ages. But some people are at increased risk for getting pneumonia and for complications from the disease, including adults over age 65, people with chronic lung disease, people who have illnesses such as diabetes or chronic lung disease1, people who smoke, people who are immunocompromised due to cancer treatment or taking certain medications, and people with other serious illnesses such as heart disease2.

In addition to its own possible complications, pneumonia can lead to the worsening of pre-existing conditions, hospitalization, or even death. In fact, according to the Canadian Institute for Health Information, pneumonia was in the top 10 reasons for admission to hospital for all ages in many provinces in 2021-2022 and that same year, it was the number 10 reason for hospitalization for adults aged 65 and over across Canada3. It was also the number eight cause of death in 2018 amongst people living in Canada who were between the ages of 65 and 74 years at time of death4.

Pneumonia can seriously impact quality of life

Dr. Marla Shapiro, a family doctor and professor in the Department of Family and Community Medicine at the University of Toronto, says that for seniors, pneumonia can truly be life-changing. “Your pre-pneumonia lung capacity may not return. You may have less energy and become more sedentary and lose your independence. It can cause increased frailty. It can impact your quality of life,” she says. 

Dr. Shapiro notes that recurrent hospitalization with pneumonia in frail patients 65 years of age and older may be associated with a higher rate of death one year after being discharged5. “Also, in older people and adults hospitalized with pneumonia, there’s a higher rate of cardiovascular complications. For example, following hospitalization for pneumonia, there’s roughly a 19 per cent chance of a negative cardiac event, such as heart failure6,” she says. 

But one way to help prevent pneumonia is vaccination7,8,9,10.

More awareness needed regarding pneumococcal vaccination 

Most adults only receive one pneumococcal vaccination in their lifetime, while those with risk factors may receive another dose. The National Advisory Committee on Immunization set a target that by 2025, 80 per cent of adults aged 65 and over have one dose of pneumococcal vaccine11. But uptake is slow.

In 2021, 54.8 per cent of seniors 65 and older had received the vaccine, along with 26.2 per cent of adults aged 18 to 64 with chronic medical conditions, such as asthma, lung disease, diabetes, and liver and heart disease12.

“There’s a lack of awareness. Many adults don’t even know there are pneumococcal vaccines. Others don’t think they’re recommended,” says Dr. Shapiro.

Vaccination is a strategy to help protect yourself 

There has been significant progress made to help protect against pneumonia with the introduction of pneumococcal vaccines. However, the pattern of disease in adults has changed due to the benefit afforded to adults from routine childhood vaccines. Vaccination is still recommended in adults to help protect against pneumonia13.

Older adults or younger adults with chronic conditions can ask their doctor about pneumococcal vaccination, Dr. Shapiro says. Other ways to help prevent pneumonia may include washing your hands frequently, quitting smoking and maintaining your general health such as a healthy diet, rest, and regular exercise. 


To learn more about vaccination, talk to your health care provider.


This article was sponsored by Merck Canada Inc.

Pneumococcal vaccination may not protect everyone who gets vaccinated. Side effects and allergic reactions can occur. Ask your health care professional if pneumococcal vaccination is right for you.
© 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

1CA Canadian Lung Association.“Pneumonia Causes,” paragraph three. https://www.lung.ca/causes-3
2CA Canadian Lung Association. “Pneumonia Causes,” paragraph nine. https://www.lung.ca/causes-3
3Canadian Institute for Health Information (CIHI). 2022. “Inpatient Hospitalization Statistics, 2021–2022.” https://www.cihi.ca/en/hospital-stays-in-canada Download Data Tables – Table 3.
4Statistics Canada. “Leading causes of death, total population, by age group.” https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310039401
5PubMed. “Recurrent hospitalisation with pneumonia is associated with higher 1-year mortality in frail older people.” https://pubmed.ncbi.nlm.nih.gov/23941077/ Abstract – Background.
6PubMed Central. “Cardiovascular Complications in Community-Acquired Pneumonia.”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695472/ Section 6 – Viral and Bacterial Infections-Related Cardiotoxicity.
7Pfizer Canada ULC 2019 – Prevnar 13. Health Canada. https://pdf.hres.ca/dpd_pm/00052583.PDF
8Pfizer Canada ULC 2023 – Prevnar 20. Health Canada. https://pdf.hres.ca/dpd_pm/00073367.PDF
9GlaxoSmithKline Inc. – SYNFLORIX. Health Canada. https://pdf.hres.ca/dpd_pm/00073322.PDF
10Merck Canada Inc. – VAXNEUVANCE. Health Canada. https://pdf.hres.ca/dpd_pm/00071531.PDF
11CA Public Health Agency of Canada. “Public health level recommendations onthe use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines.” https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html Section VI. Ethics, Equity, Feasibility and Acceptability Considerations.
12CA Public Health Agency of Canada. “Vaccine Uptake in Canadian Adults 2021.” https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/highlights-2020-2021-seasonal-influenza-survey/full-report.html#a5.4
13CA Elsevier. “Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specificurine antigen detection assay.” https://www.sciencedirect.com/science/article/pii/S0264410X22002468?via%3Dihub Section 4 – Discussion
Next article